Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Avoid Heparin "Bridging" When Implanting Cardiac Devices: Study
Link ID 25462
Title Avoid Heparin "Bridging" When Implanting Cardiac Devices: Study
Url http://www.medscape.com/viewarticle/722028?src=rss
Description Heparin bridging while withholding warfarin before implantation of a heart rhythm device substantially increases the risk of bleeding, new research shows. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date May 20, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Case #3: Anti-TNF Failure: What Next? (Slides With Audio)
  Review the value of citrullinated peptide antibodies in predicting clinical outcomes for patients with undifferentiated or probable rheumatoid arthritis (RA).
Category:   Articles > Pharmacists


2. Infliximab May Induce Remission in Refractory Systemic Necrotizing Vasculitides
  Long-term follow-up of patients with systemic necrotizing vasculitides refractory to standard treatment indicates that therapy with the tumor necrosis factor (TNF)-alpha blocker infliximab is safe and effective, according to French researchers. Reuters Health Information
Category:   Articles > Pharmacists


3. Label Change for Natalizumab; End of Road for CladribineLabel Change for Natalizumab; End of Road fo
  The European Commission has allowed inclusion of JC antibody status as a risk factor for PML with natalizumab, whereas Merck Serono announced they will not pursue approval for cladribine in MS. br / iMedscape Medical News/i
Category:   Articles > Pharmacists


4. Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
  Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
Category:   Articles > Pharmacists


5. Ritonavir-Lopinavir Regimen Causes 10-Fold Reduction in HIV Load in CSF
  A regimen of lopinavir plus ritonavir (LPV-rtv) alone for three weeks reduces HIV RNA in cerebrospinal fluid (CSF) by a factor of ten in most HIV-infected patients. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS